Renaissance Technologies’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $72.8K | Buy |
241,000
+22,000
| +10% | +$6.64K | ﹤0.01% | 3345 |
|
2025
Q1 | $62.4K | Buy |
219,000
+11,700
| +6% | +$3.33K | ﹤0.01% | 3265 |
|
2024
Q4 | $122K | Sell |
207,300
-245,487
| -54% | -$144K | ﹤0.01% | 3258 |
|
2024
Q3 | $202K | Buy |
452,787
+181,299
| +67% | +$80.9K | ﹤0.01% | 3125 |
|
2024
Q2 | $719K | Buy |
271,488
+9,164
| +3% | +$24.3K | ﹤0.01% | 2507 |
|
2024
Q1 | $719K | Sell |
262,324
-3,076
| -1% | -$8.43K | ﹤0.01% | 2686 |
|
2023
Q4 | $645K | Sell |
265,400
-17,500
| -6% | -$42.5K | ﹤0.01% | 2658 |
|
2023
Q3 | $571K | Sell |
282,900
-155,900
| -36% | -$315K | ﹤0.01% | 2647 |
|
2023
Q2 | $1.29M | Buy |
438,800
+126,935
| +41% | +$374K | ﹤0.01% | 2303 |
|
2023
Q1 | $780K | Buy |
311,865
+229,765
| +280% | +$575K | ﹤0.01% | 2632 |
|
2022
Q4 | $260K | Sell |
82,100
-152,903
| -65% | -$484K | ﹤0.01% | 3294 |
|
2022
Q3 | $698K | Buy |
+235,003
| New | +$698K | ﹤0.01% | 2718 |
|
2022
Q2 | – | Sell |
-37,400
| Closed | -$505K | – | 4209 |
|
2022
Q1 | $505K | Sell |
37,400
-76,400
| -67% | -$1.03M | ﹤0.01% | 3185 |
|
2021
Q4 | $1.48M | Buy |
113,800
+61,067
| +116% | +$796K | ﹤0.01% | 2371 |
|
2021
Q3 | $495K | Buy |
+52,733
| New | +$495K | ﹤0.01% | 2896 |
|